Michael Boyne

Michael Boyne

Company: COUR Pharmaceuticals

Job title: Vice President of Product Development & Analytics


Exploring T Cells: Treg Cell interaction & their Implications in Aiding Therapeutic Strategies 10:30 am

Unravelling the Diversity of B&T Cell Directed Drug Modalities Peripheral tolerance, preventing autoimmune diseases and limiting chronic inflammatory diseases Treg instability, plasticity and tissue-specific Treg cellsRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.